Cor Berrevoets

Cor Berrevoets is an active researcher in the Medical Oncology department at Erasmus Medical Center, specializing in tumor immunology with particular expertise in T cell and macrophage interactions within the tumor microenvironment. His research focuses on understanding how immune cells influence cancer progression, metastasis, and response to immunotherapies.

His primary research interests include Tumor Immunology, Cancer Immunotherapy, Macrophage Biology, T Cell Biology, and Breast Cancer Metastasis mechanisms. Berrevoets' work particularly examines how T lymphocytes facilitate brain metastasis of breast cancer and how tumor-associated macrophages can be reprogrammed for therapeutic benefit. His research bridges fundamental immunology with translational applications in oncology.

Analysis of his recent publications reveals consistent focus on tumor-immune interactions, particularly how T cells and macrophages influence metastasis and response to therapy. His work spans breast cancer brain metastasis mechanisms, macrophage reprogramming using β-glucans, and combination immunotherapies for gliomas. The research demonstrates strong translational orientation with multiple studies connecting in vitro findings to clinical applications.

While specific awards aren't detailed in the profile, his publications have garnered significant attention with multiple papers receiving over 40 citations each and being referenced in patents. His work has been picked up by news outlets and widely shared on social media, indicating impact beyond academic circles.

Berrevoets collaborates extensively within the Erasmus MC research ecosystem, particularly with the Debets laboratory which focuses on T cell receptor engineering and cancer immunotherapy. His work appears to be integrated within larger research programs investigating novel immunotherapeutic approaches for solid tumors, particularly those involving the tumor microenvironment and metastatic processes.